Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao, Olapade A. James, Linda M. Mann, Amin A. Mohammad, Anthony O. Okorodudu, Michael G. Bissell, John R. Petersen

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

Original languageEnglish (US)
Pages (from-to)13-15
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Issue number1-2
StatePublished - Jan 1997

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis'. Together they form a unique fingerprint.

Cite this